Mill Capital Management LLC Has $25.01 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Mill Capital Management LLC reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 4.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 47,757 shares of the healthcare conglomerate's stock after selling 2,062 shares during the period. UnitedHealth Group comprises 2.0% of Mill Capital Management LLC's portfolio, making the stock its 16th largest position. Mill Capital Management LLC's holdings in UnitedHealth Group were worth $25,013,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in UNH. Archford Capital Strategies LLC increased its stake in UnitedHealth Group by 62.9% during the first quarter. Archford Capital Strategies LLC now owns 14,564 shares of the healthcare conglomerate's stock valued at $7,628,000 after purchasing an additional 5,625 shares during the last quarter. Strategic Investment Advisors MI increased its stake in UnitedHealth Group by 10.9% during the first quarter. Strategic Investment Advisors MI now owns 2,878 shares of the healthcare conglomerate's stock valued at $1,507,000 after purchasing an additional 283 shares during the last quarter. Penn Davis Mcfarland Inc. increased its stake in UnitedHealth Group by 4.6% during the first quarter. Penn Davis Mcfarland Inc. now owns 70,685 shares of the healthcare conglomerate's stock valued at $37,021,000 after purchasing an additional 3,138 shares during the last quarter. Unison Asset Management LLC increased its stake in UnitedHealth Group by 1.4% during the first quarter. Unison Asset Management LLC now owns 18,547 shares of the healthcare conglomerate's stock valued at $10,085,000 after purchasing an additional 256 shares during the last quarter. Finally, Cornerstone Wealth Group LLC increased its stake in UnitedHealth Group by 18.8% during the first quarter. Cornerstone Wealth Group LLC now owns 14,535 shares of the healthcare conglomerate's stock valued at $7,613,000 after purchasing an additional 2,305 shares during the last quarter. Institutional investors own 87.86% of the company's stock.

Insider Transactions at UnitedHealth Group

In other news, CEO Stephen J. Hemsley acquired 86,700 shares of the company's stock in a transaction that occurred on Friday, May 16th. The shares were purchased at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the acquisition, the chief executive officer now owns 679,493 shares of the company's stock, valued at approximately $196,081,295.01. This represents a 14.63% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Timothy Patrick Flynn purchased 1,533 shares of the stock in a transaction on Wednesday, May 14th. The shares were bought at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the acquisition, the director now owns 6,033 shares of the company's stock, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased 109,408 shares of company stock valued at $31,607,768 over the last three months. 0.28% of the stock is owned by corporate insiders.

UnitedHealth Group Trading Up 2.1%

UNH stock traded up $6.23 during mid-day trading on Friday, reaching $308.85. 13,584,804 shares of the stock traded hands, compared to its average volume of 7,465,895. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 52-week low of $248.88 and a 52-week high of $630.73. The company has a market cap of $280.17 billion, a P/E ratio of 12.93, a P/E/G ratio of 1.43 and a beta of 0.44. The stock's fifty day moving average is $336.21 and its 200-day moving average is $454.51.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. During the same period last year, the company earned $6.91 earnings per share. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were given a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.86%. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group's dividend payout ratio is 37.02%.

Analysts Set New Price Targets

Several equities analysts have recently commented on UNH shares. Baird R W lowered shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, June 11th. Mizuho lowered their price target on shares of UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating for the company in a research report on Friday, May 16th. Truist Financial restated a "buy" rating and set a $360.00 price target (down previously from $580.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Wells Fargo & Company restated an "overweight" rating on shares of UnitedHealth Group in a research report on Friday, June 6th. Finally, Erste Group Bank lowered shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. One analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have given a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $415.57.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.